New Zealand vs Western Pacific (WHO region): New cases tested for RR-/MDR-TB
New Zealand
100.0%
in 2014
Western Pacific (WHO region)
89.0%
in 2024
New Zealand rank
1st
Western Pacific (WHO region) rank
2nd
New cases tested for RR-/MDR-TB over time
- New Zealand
- Western Pacific (WHO region)
How they compare
New Zealand currently reports 100.0% against 89.0% in Western Pacific (WHO region), a difference of 11.0%.
That makes New Zealand's figure about 1.1 times Western Pacific (WHO region)'s.
The two have swapped places 2 times across 10 shared years of data; in 2005 it was New Zealand ahead.
New Zealand ranks 1st and Western Pacific (WHO region) ranks 2nd of 192 countries.
New Zealand has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | New Zealand | Western Pacific (WHO region) | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 100.0% | 0.9% | 99.1% | New Zealand |
| 2010s | 80.5% | 6.4% | 74.1% | New Zealand |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher new cases tested for rr-/mdr-tb, New Zealand or Western Pacific (WHO region)?
- New Zealand, at 100.0% against 89.0% in Western Pacific (WHO region) as of 2014.
- What is the difference in new cases tested for rr-/mdr-tb between New Zealand and Western Pacific (WHO region)?
- 11.0%, with New Zealand ahead.
- How many years of comparable data are there for New Zealand and Western Pacific (WHO region)?
- 10 years are reported by both, from 2005 to 2014.
- How do New Zealand and Western Pacific (WHO region) rank globally for new cases tested for rr-/mdr-tb?
- New Zealand ranks 1st and Western Pacific (WHO region) ranks 2nd of 192 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as New cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.